JPH09274048A - Pretreatment apparatus - Google Patents

Pretreatment apparatus

Info

Publication number
JPH09274048A
JPH09274048A JP8082541A JP8254196A JPH09274048A JP H09274048 A JPH09274048 A JP H09274048A JP 8082541 A JP8082541 A JP 8082541A JP 8254196 A JP8254196 A JP 8254196A JP H09274048 A JPH09274048 A JP H09274048A
Authority
JP
Japan
Prior art keywords
needle
tank
sample
diluting
dilution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8082541A
Other languages
Japanese (ja)
Other versions
JP3572792B2 (en
Inventor
Shingo Fukunaga
信吾 福永
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tosoh Corp
Original Assignee
Tosoh Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tosoh Corp filed Critical Tosoh Corp
Priority to JP08254196A priority Critical patent/JP3572792B2/en
Priority to EP97302315A priority patent/EP0800073B1/en
Priority to US08/832,670 priority patent/US6066298A/en
Priority to DE69730893T priority patent/DE69730893T2/en
Publication of JPH09274048A publication Critical patent/JPH09274048A/en
Priority to US09/432,776 priority patent/US6190614B1/en
Application granted granted Critical
Publication of JP3572792B2 publication Critical patent/JP3572792B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/38Diluting, dispersing or mixing samples
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N35/1004Cleaning sample transfer devices
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N35/1079Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices with means for piercing stoppers or septums

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a pretreatment apparatus in which the amount of a cleaning solution required to clean a dilution tank can be reduced and in which a liquid sample or the like can be diffused and mixed in a short time and efficiently by installing a pretreatment tank or the like in which the dilution tank and a drain tank are formed integrally. SOLUTION: A needle 25 sucks a blood sample 24 from a vacuum blood sampling pipe 23. After that, by the motion of a needle holding mechanism 26, it is then moved onto a pretreatment tank 30 in which a dilution tank 30b and a drain tank 30a are formed integrally. In this position, valves 34, 35, 36 are opened, a diluting and cleaning solution 21 is supplied to a needle cleaning block 28, and the outer circumference of the needle 25 is cleaned. Then, the needle 25 is moved onto the dilution tank 30b so as to discharge the blood sample. After that, the valves 34, 35, 36 are changed over, and the solution 21 is discharged and diluted according to a dilution ratio. The diluted sample is mixed in a mixing flow passage 32, and the diluted sample which is returned to the dilution tank 305 is sucked by the needle 25 so as to be taken into a sample loop 33a inside a sample injector 33. At a final stage, the diluted sample which is left is thrown away.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、化学や生化学の分野で
液体試料を分析するための装置に関し、詳しくはのニー
ドルを用いて液体試料を採取する際の、ニードルの洗浄
及び採取した試料の希釈等の前処理を行なうための装置
及び方法に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an apparatus for analyzing a liquid sample in the fields of chemistry and biochemistry, and more specifically, when cleaning a liquid sample using a needle, cleaning of the needle and the sample collected The present invention relates to an apparatus and a method for performing a pretreatment such as diluting.

【0002】[0002]

【従来の技術】例えば液体クロマトグラフィーを用いた
糖化ヘモグロビン分析等においては、ゴムキャップを有
する管(真空採血管)内の血液試料の一定量を採取し、
当該試料中の糖化ヘモグロビン成分量を分析する等の操
作が行われている。
2. Description of the Related Art In glycated hemoglobin analysis using liquid chromatography, for example, a fixed amount of a blood sample in a tube (vacuum blood collection tube) having a rubber cap is collected,
Operations such as analyzing the amount of glycated hemoglobin component in the sample are performed.

【0003】この操作は、具体的には、真空採血管のゴ
ムキャップを貫通し得る針状のニードルを、ゴムキャッ
プ中央部の直径約5mm程度の管通場所を正確に貫通さ
せ、一定量の血液試料を採取し、血液試料を任意の倍率
に希釈し、分析カラムに導くことからなる。従って、実
際に試料をカラムに供するまでに、採取(サンプリン
グ)、希釈という前処理が必要である。また糖化ヘモグ
ロビン分析においては、試料を分析カラムに供する前に
赤血球を溶血させるという前処理も必要である。更に、
複数の血液試料を連続的に分析するためには、操作に先
立ってニードル等の洗浄という前処理が必要である。
In this operation, specifically, a needle-like needle capable of penetrating a rubber cap of a vacuum blood collection tube is accurately penetrated through a pipe passage place having a diameter of about 5 mm at a central portion of the rubber cap, and a predetermined amount of the needle is inserted. It consists of taking a blood sample, diluting the blood sample to any magnification and introducing it into an analytical column. Therefore, pretreatment such as collection (sampling) and dilution is necessary before the sample is actually applied to the column. Further, in the analysis of glycated hemoglobin, a pretreatment of hemolyzing red blood cells before the sample is applied to the analytical column is also necessary. Furthermore,
In order to continuously analyze a plurality of blood samples, a pretreatment such as washing of a needle or the like is required prior to the operation.

【0004】このように、糖化ヘモグロビン分析装置に
限らず、種々の分析装置においては、装置の各構成部品
を制御して複雑な動作を行わせ、かつ、洗浄や希釈のた
めの特別の部品を具備させている。
As described above, not only in the glycated hemoglobin analyzer, but also in various analyzers, each component of the device is controlled to perform a complicated operation, and special components for washing and dilution are provided. It is equipped.

【0005】例えば糖化ヘモグロビン分析装置等のよう
な、血液を分析する装置を例として、以下、図1により
その前処理を説明する。糖化ヘモグロビン分析装置にお
いては、ゴムキャップ付の真空採血間から血液試料を再
現性よく吸引し、試料の持ち込み等によるコンタミネー
ションを排除でき、一般的に200〜400倍程度の希
釈の再現性が良好であることが要求される。
As an example, an apparatus for analyzing blood, such as a glycated hemoglobin analyzer, will be described below with reference to FIG. In the glycated hemoglobin analyzer, a blood sample can be suctioned with good reproducibility from between vacuum blood collection with a rubber cap, contamination due to bringing in the sample can be eliminated, and reproducibility of about 200 to 400 times dilution is generally good. Is required.

【0006】まず、ニードル1をサンプリング位置2に
移動させ、ゴムキャップ付の真空採血管3へゴムキャッ
プを貫通して下降させ、第一シリンジ4の往復動により
所定の血液試料を吸引する。ここで、再現性よく血液試
料を吸引するには前記所定量を3マイクロl以上とする
必要がある。ここで、第一シリンジ4による吸引を実現
するため、第一バルブ5は閉塞しておく。
[0006] First, the needle 1 is moved to the sampling position 2, penetrates the rubber cap to the vacuum blood collection tube 3 with the rubber cap, and is lowered, and a predetermined blood sample is sucked by the reciprocating movement of the first syringe 4. Here, in order to aspirate a blood sample with good reproducibility, it is necessary to set the predetermined amount to 3 μl or more. Here, in order to realize the suction by the first syringe 4, the first valve 5 is closed.

【0007】次にニードルを希釈槽6に移動して吸引し
た血液試料を吐出し、第二シリンジ7によって所定量の
溶液(希釈溶液)を希釈ノズル8から噴出し、血液試料
を所定の倍率(通常、200〜400倍)に希釈する。
希釈ノズル8からの溶液の噴出が終了した後、第一バル
ブ及び第二バルブ9を切り替えて希釈試料を6方弁を利
用したサンプルインジェクタ10に導入し、分析カラム
に希釈後の試料を供する。なお、再現性良く希釈操作を
行うためにも、血液試料の採取量は3マイクロl以上と
する必要がある。
Next, the needle is moved to the diluting tank 6 to discharge the sucked blood sample, and a predetermined amount of solution (diluting solution) is ejected from the diluting nozzle 8 by the second syringe 7 to make the blood sample have a predetermined magnification ( It is usually diluted 200 to 400 times).
After the ejection of the solution from the dilution nozzle 8 is completed, the first valve and the second valve 9 are switched to introduce the diluted sample into the sample injector 10 using the 6-way valve, and the diluted sample is supplied to the analytical column. In order to perform the dilution operation with good reproducibility, it is necessary to collect the blood sample in an amount of 3 μl or more.

【0008】以上の操作の完了後、新たな血液試料を分
析するために希釈槽及びニードルの洗浄を行う。ニード
ルの洗浄は、ニードル洗浄ブロック11に洗浄ポンプ1
2によって溶液を流す方法と、ニードル洗浄槽13でニ
ードルから洗浄溶液を吐出させ、第三バルブ14を開放
し、吸引ポンプ15を作動させ、汚染された洗浄溶液を
真空チャンバ16に吸引し、あるタイミングで第四バル
ブ17を開き、排出部18に排出する方法がある。
After the above operation is completed, the diluting tank and the needle are washed in order to analyze a new blood sample. To clean the needle, clean the needle cleaning block 11 with the cleaning pump 1
2, the cleaning solution is discharged from the needle in the needle cleaning tank 13, the third valve 14 is opened, the suction pump 15 is operated, and the contaminated cleaning solution is sucked into the vacuum chamber 16. There is a method of opening the fourth valve 17 at a timing and discharging to the discharging portion 18.

【0009】希釈槽6の洗浄は、希釈槽にニードル1又
は希釈ノズル8から洗浄溶液を満杯になるまで吐出さ
せ、第五バルブ19を開き、吸引ポンプ15を作動さ
せ、汚染された洗浄溶液を真空チャンバ16に吸引し、
あるタイミングで第四バルブ17を開き、排出部18に
排出させることで行われる。
To wash the diluting tank 6, the washing solution is discharged from the needle 1 or the diluting nozzle 8 into the diluting tank until it is full, the fifth valve 19 is opened, and the suction pump 15 is operated to remove the contaminated washing solution. Suck into the vacuum chamber 16,
It is performed by opening the fourth valve 17 at a certain timing and causing the discharging portion 18 to discharge the gas.

【0010】ここで、試料間のコンタミネーションを減
少させるためには、ニードル1、ニードル洗浄槽13、
ニードル洗浄ブロック11、希釈槽6及び試料供給部1
0とこれらを接続する配管内部の洗浄が要求される。
Here, in order to reduce the contamination between the samples, the needle 1, the needle washing tank 13,
Needle washing block 11, dilution tank 6 and sample supply unit 1
It is required to clean the inside of the pipe connecting 0 and these.

【0011】[0011]

【発明が解決しようとする課題】前述の糖化ヘモグロビ
ン分析装置等の、特に血液試料等の液体試料を取り扱う
従来の分析装置においては、再現性を向上させるために
真空採血管から血液試料を3マイクロl以上吸引するこ
とと、一般的な血液試料の希釈倍率が200倍〜400
倍であることから、希釈槽の容量を1500マイクロl
程度以上とする必要があり、この結果、洗浄操作には3
000マイクロl程度以上の多量の洗浄溶液が必要にな
るという課題がある。
SUMMARY OF THE INVENTION In the conventional glycated hemoglobin analyzers and the like, particularly conventional analyzers that handle liquid samples such as blood samples, in order to improve reproducibility, a blood sample from a vacuum blood collection tube is used in an amount of 3 micron. Aspirate more than 1 and the dilution ratio of general blood sample is 200 to 400
Since it is double, the capacity of the dilution tank is 1500 μl.
As a result, it is necessary to make the washing operation 3 or more.
There is a problem that a large amount of cleaning solution of about 000 μl or more is required.

【0012】また、従来の装置では、希釈槽の洗浄のた
めに専用の吸引ポンプと専用バルブが必要であり、ニー
ドル洗浄のためにも専用の送液ポンプと専用バルブが必
要である。このため、装置が複雑になるだけでなく、各
部品の操作も複雑となり、結果的に前処理に長時間が必
要になるという課題がある。
Further, in the conventional apparatus, a dedicated suction pump and a dedicated valve are required to wash the dilution tank, and a dedicated liquid feed pump and a dedicated valve are also required to wash the needle. Therefore, there is a problem that not only the apparatus becomes complicated, but also the operation of each component becomes complicated, and as a result, a long time is required for the pretreatment.

【0013】また図1に示したような従来の装置では、
ニードル1又は希釈ノズル8からの洗浄溶液の吐出によ
って希釈槽6を満杯にした後に、バルブ19を開き、吸
引ポンプ15によって吸引することから、希釈槽の上端
部の洗浄が不十分となり、コンタミネーションが発生す
る可能性を排除できないだけでなく、場合によってはニ
ードルやバルブの詰まり発生等の不具合を生じる原因と
なるため、定期的に希釈槽6、バルブ19及び吸引ポン
プ15を外して手作業で洗浄等しなければならない等、
煩雑なメンテナンスが必要となる課題がある。
Further, in the conventional device as shown in FIG. 1,
After the diluting tank 6 is filled with the cleaning solution discharged from the needle 1 or the diluting nozzle 8, the valve 19 is opened and suction is performed by the suction pump 15, so that the upper end of the diluting tank is insufficiently cleaned, and contamination is caused. Not only is it possible to eliminate the possibility that this will occur, but it may cause problems such as clogging of the needle and valve in some cases. Therefore, periodically diluting the diluting tank 6, valve 19 and suction pump 15 manually. Such as having to wash
There is a problem that complicated maintenance is required.

【0014】特に、ゴムキャップ付き真空採血間の場合
はニードルがゴムキャップを貫通するため、ニードルに
付着したゴムキャップの摩耗カスが各部に流出する可能
性もあり、この場合には分析カラムに至る全ての経路で
目詰まりが生じる恐れが発生してしまうという課題があ
る。
In particular, during vacuum blood collection with a rubber cap, since the needle penetrates the rubber cap, there is a possibility that wear debris of the rubber cap adhering to the needle may flow out to each portion, and in this case, it reaches the analytical column. There is a problem that clogging may occur in all routes.

【0015】更に、液体試料の吸引後、ニードルは希釈
槽に移動し、希釈槽に液体試料を吐出した後に希釈溶液
を任意の倍率(200〜400倍)となるように希釈ノ
ズルから吐出するが、この際、希釈槽の中心から外れる
斜め上方向から角度をもって希釈溶液を希釈槽内に噴出
し、希釈槽内で渦巻きを発生させることによって希釈効
率を向上させている。しかし、噴出する希釈溶液の量が
希釈倍率によって決定されてしまうため、特に希釈倍率
が低い場合には血液試料と希釈溶液の混合が不十分であ
るという課題がある。
Further, after suctioning the liquid sample, the needle moves to the diluting tank, and after ejecting the liquid sample into the diluting tank, the diluting solution is ejected from the diluting nozzle so as to have an arbitrary magnification (200 to 400 times). At this time, the diluting solution is jetted into the diluting tank at an angle from an obliquely upward direction deviating from the center of the diluting tank and swirling is generated in the diluting tank to improve the diluting efficiency. However, since the amount of the diluted solution to be ejected is determined by the dilution ratio, there is a problem that the blood sample and the diluted solution are insufficiently mixed especially when the dilution ratio is low.

【0016】また、特に血液を液体試料とする場合、そ
の前処理には希釈のみならず血球の溶血操作も含まれる
ことがあるが、以上のような希釈操作のみでは溶血が不
十分となり易い。
Further, particularly when blood is used as a liquid sample, the pretreatment thereof may include not only dilution but hemolysis of blood cells, but hemolysis tends to be insufficient only by the above-mentioned dilution.

【0017】[0017]

【課題を解決するための手段】本発明者は、従来技術に
見られる課題を解決すべく、鋭意検討を行った結果、本
発明を完成させた。即ち本発明は、少なくとも、前処理
されるべき液体試料の一定量を採取するためのニードル
と、当該ニードルを上下動可能に保持するニードル保持
機構と、ニードル保持機構を水平方向に移動可能に保持
する基台と、ニードル保持機構に設置されニードルと共
に水平方向に移動可能であるが上下動しないニードル洗
浄ブロックと、液体試料の希釈のための希釈槽と排液を
廃棄するための排液槽が一体に形成された前処理槽と、
希釈された液体試料を混合するための混合流路と、これ
ら各部品を連結する配管及び少なくとも二つのシリンジ
とから構成される、前処理装置である。以下、糖化ヘモ
グロビン分析装置の前処理部として適用した本発明の装
置を図面に基づき詳細に説明する。
The present inventor has completed the present invention as a result of extensive studies to solve the problems found in the prior art. That is, the present invention, at least, a needle for collecting a fixed amount of a liquid sample to be pretreated, a needle holding mechanism for holding the needle so as to be movable up and down, and a needle holding mechanism for holding the needle movable in a horizontal direction. The base, the needle wash block installed in the needle holding mechanism that can move horizontally with the needle but does not move up and down, the dilution tank for diluting the liquid sample, and the drain tank for discarding the drainage liquid. A pretreatment tank integrally formed,
The pretreatment device comprises a mixing flow path for mixing a diluted liquid sample, a pipe connecting these components, and at least two syringes. Hereinafter, the device of the present invention applied as a pretreatment unit of a glycated hemoglobin analyzer will be described in detail with reference to the drawings.

【0018】図2は本発明の構成を示した図である。本
発明における前処理装置は、液体試料の採取、希釈、混
合及びコンタミネーションを防止するための各部品の洗
浄を前処理として行う。このような前処理を行うため、
本発明では、液体試料の希釈のための希釈溶液及び装置
各部品の洗浄のための洗浄溶液を使用する。これらの溶
液は、異なる2種類以上の溶液を使用することも可能で
あるが、図2に示したように、単一の溶液21を用いる
こともできる。即ち、糖化ヘモグロビン分析装置におい
ては、希釈と洗浄を例えば赤血球を溶血可能な塩濃度を
有し、かつ、洗浄のための界面活性剤を含むの単一の溶
液等で行うことが可能である。図2に示した装置では、
希釈・洗浄溶液21はゴムキャップ22を有する真空採
血管23中の血液試料24を希釈すると共に、血液試料
を採取した後はニードル25等の洗浄溶液としての機能
をも兼ね備えている。なお、希釈・洗浄溶液として低塩
濃度溶液を用いた場合、単にこれで血液試料を希釈のみ
では溶血は不完全になり易いが、後に説明する混合流路
での十分な混合により十分な溶血を実現することもでき
る。
FIG. 2 is a diagram showing the configuration of the present invention. The pretreatment device according to the present invention performs collection of liquid sample, dilution, mixing, and cleaning of each component to prevent contamination as pretreatment. In order to perform such preprocessing,
The present invention uses a diluting solution for diluting a liquid sample and a washing solution for washing each part of the device. As these solutions, it is possible to use two or more different solutions, but it is also possible to use a single solution 21 as shown in FIG. That is, in the glycated hemoglobin analyzer, it is possible to perform dilution and washing with, for example, a single solution having a salt concentration capable of hemolyzing erythrocytes and containing a detergent for washing. In the device shown in FIG.
The diluting / washing solution 21 not only dilutes the blood sample 24 in the vacuum blood collection tube 23 having the rubber cap 22 but also has a function as a washing solution for the needle 25 and the like after the blood sample is taken. When a low salt concentration solution is used as the diluting / washing solution, hemolysis is likely to be incomplete by simply diluting the blood sample, but sufficient hemolysis can be achieved by sufficient mixing in the mixing channel described later. It can also be realized.

【0019】図2の装置では、第一シリンジ31、洗浄
・希釈溶液21を保持するタンク、第一バルブ34及び
これらを連結する配管から構成される流路(溶液吸引
系)、第一シリンジ31、通常の6方インジェクション
バルブを利用したサンプルインジェクタ33、ニードル
25、第一バルブ34と第二バルブ35及びこれらを連
結する配管から構成される流路(サンプリング系)、第
一シリンジ31、ニードル洗浄ブロック28、第一バル
ブ34、第二バルブ35、第三バルブ36及びこれらを
連結する配管から構成される流路(ニードル洗浄系)、
第一シリンジ31、混合流路32、希釈槽30b、第一
バルブ34、第二バルブ35、第三バルブ36及びこれ
らを連結する配管から構成される流路(混合流路系)及
び血液試料を吸引するための第二シリンジ29、ニード
ル25及びこれらを連結する配管からなる系を包含して
いる。このように図2に示した本発明の構成では、希釈
・洗浄溶液の吸引、吐出用の第一シリンジ31及び血液
試料を吸引、吐出する第二シリンジ29を有するが、そ
の役割の一部を別途追加したシリンジに負わせることも
可能である。
In the apparatus of FIG. 2, a first syringe 31, a tank for holding the washing / diluting solution 21, a first valve 34 and a flow path (solution suction system) composed of a pipe connecting these, a first syringe 31. , A sample injector 33 using a normal 6-way injection valve, a needle 25, a flow path (sampling system) composed of a first valve 34 and a second valve 35, and a pipe connecting these, a first syringe 31, a needle wash A flow path (needle cleaning system) composed of the block 28, the first valve 34, the second valve 35, the third valve 36, and a pipe connecting these
A flow path (mixing flow path system) and a blood sample that are composed of the first syringe 31, the mixing flow path 32, the diluting tank 30b, the first valve 34, the second valve 35, the third valve 36, and the pipes connecting these It includes a system including a second syringe 29 for suctioning, a needle 25, and a pipe connecting these. As described above, the configuration of the present invention shown in FIG. 2 has the first syringe 31 for sucking and discharging the diluting / washing solution and the second syringe 29 for sucking and discharging the blood sample. It is also possible to load a syringe added separately.

【0020】図2に示した本発明の装置においては、後
述する実際の液体試料の前処理に先立ち、あらかじめシ
リンジを運動させ、かつ、各バルブを切り替えてそれぞ
れの系に希釈・洗浄溶液を満たしておく。ただし、前記
混合流路系については、第一シリンジを用いて希釈槽3
0bを満たした希釈・洗浄溶液を混合流路と希釈槽の間
まで後退させ、空気層を挟んで希釈後試料と洗浄・希釈
溶液が位置し得るよう、希釈槽30b側に空気層を位置
させることが好ましい。
In the apparatus of the present invention shown in FIG. 2, prior to the actual pretreatment of the liquid sample described later, the syringe is moved in advance and each valve is switched to fill each system with the diluting / washing solution. Keep it. However, for the mixing flow channel system, a dilution tank 3 is used by using a first syringe.
The dilution / washing solution filled with 0b is moved back to between the mixing channel and the diluting tank, and the air layer is positioned on the diluting tank 30b side so that the diluted sample and the washing / diluting solution can be positioned with the air layer in between. It is preferable.

【0021】図2に示した例では、ニードル25は真空
採血管23のゴムキャップ22を貫通するため、針状で
あるが、その長さや具体的な形状等に特別の制限はな
い。
In the example shown in FIG. 2, since the needle 25 penetrates the rubber cap 22 of the vacuum blood collection tube 23, it has a needle shape, but there is no particular limitation on its length or specific shape.

【0022】ニードル25は、図中Aで示した垂直方向
へ上下動可能に、ニードル保持機構26に保持されてい
る。ニードル保持機構26は、図中Bで示した水平方向
へ移動可能に不図示の基台に保持されている。ニードル
保持機構26にはニードル洗浄ブロック28が取り付け
られいる。即ち、ニードル25は当該洗浄ブロック28
を貫通して上下動可能に構成されているが、それ自体は
上下動しないため、ニードル25の上下動によってニー
ドル洗浄ブロック28との相対的位置関係が変動するよ
うに構成されている。
The needle 25 is held by a needle holding mechanism 26 so as to be vertically movable in the vertical direction shown by A in the figure. The needle holding mechanism 26 is held by a base (not shown) so as to be movable in the horizontal direction shown by B in the figure. A needle washing block 28 is attached to the needle holding mechanism 26. That is, the needle 25 is the cleaning block 28.
Although it is configured so as to be able to move up and down by passing through, it does not move up and down, so that the relative positional relationship with the needle washing block 28 is changed by the up and down movement of the needle 25.

【0023】ニードル25は、まず基台の水平方向(B
方向)の運動により、真空採血管23から血液試料24
を採取するための位置の上部に移動する。この位置でニ
ードル保持機構26は下方向(A方向)に下降し、ニー
ドル25はゴムキャップ22を貫通して血液試料24に
浸漬される(25aの状態)。この状態で第二シリンジ
29を運動させることにより所定量の血液試料を吸引す
る。糖化ヘモグロビン分析における吸引量は、通常、3
マイクロl程度である。
First, the needle 25 is moved in the horizontal direction (B
Movement of the blood sample 24 from the vacuum blood collection tube 23
Move to the top of the position for collecting. At this position, the needle holding mechanism 26 descends downward (direction A), and the needle 25 penetrates the rubber cap 22 and is immersed in the blood sample 24 (state of 25a). By moving the second syringe 29 in this state, a predetermined amount of blood sample is sucked. The amount of aspiration in glycated hemoglobin analysis is usually 3
It is about a microliter.

【0024】血液試料の吸引後、ニードル25はニード
ル保持機構26及び基台の運動により、ニードルの外周
を洗浄するため、液体試料の希釈のための希釈槽30b
と排液を廃棄するための排液槽30aが一体に形成され
た前処理槽30の排液槽30a上に移動する。この位置
で、第一シリンジ31からニードル洗浄ブロック28に
至る経路のバルブ34、35及び36を開き、ニードル
洗浄系を開いて希釈・洗浄溶液21をニードル洗浄ブロ
ック28に供給し、ニードル25の外周を洗浄する。こ
のニードル洗浄ブロック28は、ニードルを貫通させ、
かつ、ニードルの洗浄路となるニードル外径よりも若干
大きめの内径の柱状中空部が垂直方向に構成されたブロ
ックである。この中空部はブロックの上部側面方向に設
けられた洗浄溶液導入路と連通している。洗浄溶液導入
路はバルブを介して第一シリンジ31と連結されてお
り、ニードル洗浄系が開かれると希釈・洗浄溶液21が
導入路からニードル洗浄路に導かれ、ニードル25の外
周を伝ってその外周を洗浄しながら排液槽30aへ廃棄
される。このような構成によれば、排液のための特別な
吸引ポンプ等を使用することなく、単に重力によって汚
染された希釈・洗浄溶液の排液が可能である。むろん、
排液槽30aを真空チャンバ等を介してポンプ等と連結
することも可能である。
After the blood sample is sucked, the needle 25 cleans the outer circumference of the needle by the movement of the needle holding mechanism 26 and the base, so that the diluting tank 30b for diluting the liquid sample is obtained.
And the drainage tank 30a for discarding the drainage moves to the drainage tank 30a of the pretreatment tank 30 integrally formed. At this position, the valves 34, 35 and 36 on the path from the first syringe 31 to the needle washing block 28 are opened, the needle washing system is opened to supply the dilution / washing solution 21 to the needle washing block 28, and the outer circumference of the needle 25. To wash. The needle washing block 28 allows the needle to penetrate therethrough,
Further, it is a block in which a columnar hollow portion having an inner diameter slightly larger than the outer diameter of the needle, which serves as a cleaning passage for the needle, is formed in the vertical direction. This hollow portion communicates with a cleaning solution introducing passage provided on the upper side surface of the block. The washing solution introducing passage is connected to the first syringe 31 via a valve, and when the needle washing system is opened, the diluting / washing solution 21 is guided from the introducing passage to the needle washing passage and propagates along the outer periphery of the needle 25. The outer periphery is cleaned and discarded into the drainage tank 30a. According to such a configuration, it is possible to simply discharge the diluted / cleaning solution contaminated by gravity without using a special suction pump or the like for discharging the liquid. Of course,
The drainage tank 30a can be connected to a pump or the like via a vacuum chamber or the like.

【0025】なおニードル洗浄路は、ニードルを洗浄す
るための希釈・洗浄溶液の流路であると同時に、ニード
ル洗浄ブロック28を貫通するニードル25を保持し、
ニードル25の上下運動の際のガイドとしての役目も兼
ね備えるため、その長さはできるだけ長くすることが好
ましい。しかし、後に説明するように、ニードルを洗浄
する際にニードル25を上下動させることから、この上
下動の範囲を勘案して適宜決定することができる。
The needle washing passage is a diluting / washing solution passage for washing the needle, and at the same time holds the needle 25 penetrating the needle washing block 28,
Since it also serves as a guide when the needle 25 moves up and down, its length is preferably as long as possible. However, as will be described later, since the needle 25 is moved up and down when cleaning the needle, it can be appropriately determined in consideration of the range of this up and down movement.

【0026】ニードル洗浄ブロック28の垂直方向に構
成されたニードル洗浄路の上方向末端は、Oリング等の
シール部材によりシールされ、希釈・洗浄溶液が供給さ
れた場合に上部からオーバーフローせず、下端の開放端
のみから排液されるように構成する。このOリング等の
シール部材は、ニードル25の上下運動を抑制するもの
ではなく、この状態でニードルを上下動させることによ
り、ニードル25の外周に付着したゴムキャップの摩耗
カス等をぬぐいとる効果を有する。このような上下運動
は、3回程度行なうと良い。運動の幅は、ニードルの全
体がOリング等と接触するようにすることが特に好まし
いが、少なくともゴムキャップを貫通した部分が接触す
れば十分である。また、ニードル外周への希釈・洗浄溶
液の伝わりを良好にするため、希釈・洗浄溶液導入路は
ニードル洗浄路と直角に交差するように構成し、かつ、
希釈・洗浄溶液導入路の内径をニードル洗浄路の内径よ
りも小さくすることが好ましい。
The upper end of the needle washing passage formed vertically in the needle washing block 28 is sealed by a seal member such as an O-ring so that when a diluting / washing solution is supplied, it does not overflow from the upper portion and the lower end. The liquid is drained only from the open end. The seal member such as the O-ring does not suppress the vertical movement of the needle 25. By moving the needle up and down in this state, the effect of wiping off the abrasion residue and the like of the rubber cap attached to the outer periphery of the needle 25 can be obtained. Have. It is advisable to perform such vertical movements about three times. The width of the movement is particularly preferably such that the entire needle comes into contact with the O-ring or the like, but it is sufficient if at least the portion penetrating the rubber cap comes into contact. Further, in order to improve the transmission of the diluting / washing solution to the outer circumference of the needle, the diluting / washing solution introducing passage is configured to intersect the needle washing passage at a right angle, and
The inner diameter of the diluting / washing solution introducing passage is preferably smaller than the inner diameter of the needle washing passage.

【0027】このように、液体試料の希釈のための希釈
槽と排液槽が一体に形成された前処理槽30の排液槽3
0a上で希釈・洗浄溶液を流しつつ、複数回上下運動さ
せることで外周を洗浄されたニードル25は、次に前処
理槽30の希釈槽30b上に水平に移動し、その底部ま
で下降する。この位置で第二シリンジ29からニードル
25に至る系を開き、ニードルに吸引した血液試料の全
量を吐出する。この後、バルブを切り替え、第一シリン
ジ31からニードル25に至るサンプリング系を開き、
希釈倍率に応じて希釈・洗浄溶液21をゆっくりと吐出
する。この時、希釈槽30bの容量は実際の分析に供す
る試料の量以上であれば、希釈により出現する希釈後試
料の容量以下であっても良い。希釈槽30bと排液槽3
0aは一体として形成されているが、そのしきり30c
は低くなっており、オーバーフローした希釈後試料は排
液槽30aにこぼれるように構成する。なお、排液槽3
0aにオーバーフローした希釈後試料は、単に重力のみ
で排出が可能である。
As described above, the drainage tank 3 of the pretreatment tank 30 in which the dilution tank for diluting the liquid sample and the drainage tank are integrally formed.
The needle 25 whose outer periphery has been cleaned by moving it up and down a plurality of times while flowing the diluting / cleaning solution on 0a moves horizontally on the diluting tank 30b of the pretreatment tank 30 and descends to the bottom thereof. At this position, the system from the second syringe 29 to the needle 25 is opened, and the whole amount of the blood sample sucked into the needle is discharged. After that, the valve is switched to open the sampling system from the first syringe 31 to the needle 25,
The dilution / washing solution 21 is slowly discharged according to the dilution ratio. At this time, the capacity of the diluting tank 30b may be less than or equal to the capacity of the diluted sample that appears by dilution as long as it is equal to or more than the amount of the sample to be actually used for the analysis. Dilution tank 30b and drainage tank 3
0a is formed integrally, but its edge 30c
Is so low that the overflowed diluted sample is spilled into the drainage tank 30a. The drainage tank 3
The diluted sample overflowing to 0a can be discharged only by gravity.

【0028】この希釈槽30bは、図からも把握できる
ように、その水平方向の断面積が底部から上端部にいく
ほど大きくなるように構成されている。希釈槽30bの
形状は、この断面積の変化が連続的となるようにテーパ
ー状(先細りの錐状)としても良いが、図のように3段
階程度に変化する(3種類の断面積の異なる円柱を組み
合わせたような)ステップ的な変化としても良い。この
ような構成とすることにより、血液試料の希釈・洗浄溶
液への拡散が不十分で希釈後試料に濃度勾配が生じ、比
較的高濃度の部分が排液槽30aにオーバーフローして
失われるという問題が生じることを防止できる。また、
後述するように希釈後試料はニードル25で再度吸引す
るため、その底部にニードル25の先端部が到達し得る
よう、底部の内径を考慮することが好ましい。
As can be seen from the figure, this diluting tank 30b is constructed so that its horizontal cross-sectional area increases from the bottom to the top. The shape of the diluting tank 30b may be a taper shape (tapered cone shape) so that the change of the cross-sectional area is continuous, but as shown in the figure, changes in about three stages (three different cross-sectional areas are different). It may be a step change (like combining cylinders). With such a configuration, the diffusion of the blood sample into the diluting / washing solution is insufficient and a concentration gradient occurs in the sample after dilution, and a relatively high concentration portion overflows into the drainage tank 30a and is lost. You can prevent problems. Also,
Since the sample after dilution is sucked again by the needle 25 as described below, it is preferable to consider the inner diameter of the bottom so that the tip of the needle 25 can reach the bottom.

【0029】本発明者の知見によれば、希釈槽30bの
底部は、後のニードル25による希釈後試料の良好な吸
引等のため、その断面積がニードルの外径よりも、0.
5mm〜1.5mm大きい程度の円状で、特に好ましく
は図3に示したような先細りテーパー状である。また、
その上端部付近は、希釈時の拡散状態を良好にするため
に、底部の断面積の4〜6倍程度とすることが好まし
い。
According to the knowledge of the present inventor, the bottom portion of the diluting tank 30b has a cross-sectional area of 0.
The circular shape is about 5 mm to 1.5 mm larger, and the tapered shape as shown in FIG. 3 is particularly preferable. Also,
The vicinity of the upper end portion is preferably about 4 to 6 times the cross-sectional area of the bottom portion in order to improve the diffusion state during dilution.

【0030】次に、バルブ34、35及び36を切り替
えて第一シリンジ31から前処理槽30の希釈槽30b
の下端部に至る混合流路系を開き、第一シリンジ31を
往復運動させて希釈後試料を図中のCで示した流路で往
復させる。ここで、混合流路系の希釈槽30b近傍の配
管は、図からも明らかなように配管の断面が大なる部分
と小なる部分が複数箇所連続した特殊な混合流路32と
してある。この混合流路32は、希釈後試料が当該部を
通過する際の流速を変化させることで適当な乱流を発生
させ、混合効率を向上させ、更には血液試料の溶血に効
果的である。混合流路の形状は図示したものに限定され
ず、通過する液体の流速を変化させて乱流を発生させ得
るような断面積の変化がある形状であれば制限はない。
当該経路は、好ましくは希釈槽30bと同一の容量を有
し、又はそれ以上の容積を有するように構成する。混合
流路系で混合された希釈後試料は、最終的に希釈槽に戻
される。なお、混合流路系では、空気層を挟んで希釈・
洗浄溶液と希釈後試料が位置する。この、混合流路系を
用いた操作の間、ニードルは希釈槽30bに位置させる
ことが好ましいが、いったん希釈槽30bの上部等に移
動させても良い。
Next, the valves 34, 35 and 36 are switched to switch the first syringe 31 to the dilution tank 30b of the pretreatment tank 30.
The mixing flow channel system reaching the lower end of the column is opened, and the first syringe 31 is reciprocated to reciprocate the diluted sample in the flow channel indicated by C in the figure. Here, as is clear from the figure, the pipe in the vicinity of the diluting tank 30b of the mixing flow channel system is a special mixing flow channel 32 in which a large portion and a small portion of the cross section of the pipe are continuous at a plurality of locations. The mixing channel 32 is effective for generating an appropriate turbulent flow by changing the flow rate of the diluted sample passing through the portion, improving the mixing efficiency, and further for hemolyzing the blood sample. The shape of the mixing flow path is not limited to that shown in the figure, and there is no limitation as long as the cross-sectional area changes so that the turbulent flow can be generated by changing the flow velocity of the passing liquid.
The path is preferably configured to have the same capacity as the diluting tank 30b or have a volume larger than that. The diluted sample mixed in the mixing channel system is finally returned to the dilution tank. In addition, in the mixing channel system, dilution is performed with an air layer in between.
The sample is located after washing solution and dilution. During this operation using the mixing channel system, the needle is preferably located in the diluting tank 30b, but may be once moved to the upper portion of the diluting tank 30b or the like.

【0031】混合流路系で希釈後試料を混合した後、希
釈槽30bに戻された希釈後試料の全量を、第一シリン
ジ31からニードル25に至るサンプリング系を開き、
第一シリンジ31を運動させて吸引する。図からも明ら
かなように、第一シリンジ31からニードル25に至る
サンプリング系には6方インジェクションバルブを使用
した一般的なサンプルインジェクタ33が配置されてお
り、ニードル25から吸引された希釈後試料の一定量は
サンプルインジェクタ33中のサンプルループ33aに
取り込まれる。ここで、ニードル25からサンプルルー
プ33aに至る流路容量が希釈槽3 0bの容量より大き
い場合、希釈後試料に続いて空気を取り込むためにニー
ドル25をいったん希釈槽30bの上部に移動させる等
しても良い。特に、サンプルループ33aに至るまでの
流路容量を希釈槽30bの容量と概ね同量とすることが
好ましい。更に好ましくは、バルブ35に至るまでの流
路容量を、希釈槽30bの容量と概ね同量とし、サンプ
ルループ33aが容量的に中間に位置するようにする。
After mixing the diluted sample in the mixing flow path system, the sampling system from the first syringe 31 to the needle 25 is opened for the whole amount of the diluted sample returned to the dilution tank 30b.
The first syringe 31 is moved and sucked. As is clear from the figure, a general sample injector 33 using a 6-way injection valve is arranged in the sampling system from the first syringe 31 to the needle 25, and the diluted sample aspirated from the needle 25 A fixed amount is taken into the sample loop 33a in the sample injector 33. Here, when the flow path capacity from the needle 25 to the sample loop 33a is larger than the capacity of the diluting tank 30b, the needle 25 is once moved to the upper part of the diluting tank 30b in order to take in air following the diluted sample. May be. In particular, it is preferable that the volume of the flow path leading to the sample loop 33a be approximately the same as the volume of the diluting tank 30b. More preferably, the flow path capacity up to the valve 35 is set to be approximately the same as the capacity of the diluting tank 30b, and the sample loop 33a is positioned in the middle in terms of capacity.

【0032】希釈後試料の全量をニードル25で吸引し
た後、ニードル先端を希釈槽の底部に位置させた状態で
混合流路系を開き、第一シリンジを運動させて希釈・洗
浄溶液を吐出し、希釈槽及び混合流路の洗浄を行う。こ
の洗浄により、ニードルの外周に付着した希釈後試料も
洗浄される。希釈・洗浄溶液の吐出量は、希釈槽30b
の容量を超える量とし、排液槽30aにオーバーフロー
するように操作する。この後、第一シリンジを運動させ
て希釈層に残った希釈・洗浄溶液を混合流路と希釈槽の
間まで後退させ、次回の前処理操作で空気層を挟んで希
釈後試料と洗浄・希釈溶液が位置し得るようにする。
After diluting the whole amount of the sample with the needle 25, the mixing channel system is opened with the tip of the needle positioned at the bottom of the diluting tank, and the first syringe is moved to discharge the diluting / washing solution. , Wash the dilution tank and the mixing channel. By this washing, the diluted sample attached to the outer circumference of the needle is also washed. The discharge amount of the dilution / cleaning solution is the dilution tank 30b.
The volume is set to exceed the capacity of the above, and it is operated so as to overflow into the drainage tank 30a. After this, move the first syringe to move the diluted / washed solution remaining in the diluted layer back up between the mixing channel and the dilution tank, and in the next pretreatment operation, sandwich the air layer and dilute the sample and wash / dilute. Allow the solution to be located.

【0033】前処理操作の最終段階として、ニードル2
5を希釈槽30bから排液槽30a上に移動させ、サン
プリング系を開き、第一シリンジ31の運動により希釈
・洗浄液を吐出し、サンプリング系に残った希釈後試料
を廃棄する。これにより、ニードル内部を含むサンプリ
ング系の洗浄が完了する。従って、次回の採取操作の際
にサンプリング系に残った希釈後試料等がコンタミネー
ションを生じないようになる。
As the final stage of the pretreatment operation, the needle 2
5 is moved from the diluting tank 30b to the draining tank 30a, the sampling system is opened, the diluting / cleaning liquid is discharged by the movement of the first syringe 31, and the diluted sample remaining in the sampling system is discarded. This completes the cleaning of the sampling system including the inside of the needle. Therefore, the sample after dilution remaining in the sampling system during the next sampling operation will not cause contamination.

【0034】なお、サンプルループ33a中に取り込ま
れた希釈後試料は、その後、不図示の陽イオン交換樹脂
を充填した糖化ヘモグロビン分析カラムに供される。
The diluted sample taken into the sample loop 33a is then provided to a glycated hemoglobin analysis column packed with a cation exchange resin (not shown).

【0035】[0035]

【発明の効果】本発明の前処理装置においては、血液等
の液体試料を希釈した希釈後試料が、希釈槽の容量以上
となる場合、この容量を超える部分は排液槽にオーバー
フローし、廃棄される。通常の糖化ヘモグロビン分析に
おいては、血液試料を200〜400倍に希釈する必要
があるが、一方でニードルによる血液試料の採取量は再
現性の問題等から3マイクロl以下にすることはでき
ず、この結果、希釈後試料の全てを保持しようとすると
希釈槽の容量が大きくなり、当然、希釈槽の洗浄に多く
の洗浄溶液が必要となり、更には希釈槽における血液試
料の拡散・混合が不十分になり易い。これに対して本発
明では、希釈槽の容量を積極的に小さくし、希釈槽から
オーバーフローする希釈後試料を利用して希釈槽の一次
的な洗浄を実施するのである。
In the pretreatment device of the present invention, when the diluted sample obtained by diluting a liquid sample such as blood exceeds the capacity of the diluting tank, the portion exceeding this capacity overflows into the draining tank and is discarded. To be done. In the usual glycated hemoglobin analysis, it is necessary to dilute the blood sample by 200 to 400 times, but on the other hand, the amount of the blood sample collected by the needle cannot be 3 μl or less due to the problem of reproducibility, As a result, if it is attempted to hold all of the sample after dilution, the capacity of the diluting tank becomes large, and naturally, a large amount of washing solution is required for washing the diluting tank, and further, the diffusion and mixing of the blood sample in the diluting tank are insufficient. It is easy to become. On the other hand, in the present invention, the capacity of the diluting tank is positively reduced, and the diluted sample that overflows from the diluting tank is used for the primary cleaning of the diluting tank.

【0036】このように希釈槽の容量を小さくすること
により、本発明では、希釈槽の洗浄に必要な洗浄溶液の
量を減少できる。しかも本発明では、希釈槽の形状を工
夫し、更には希釈槽に混合流路を具備させることによ
り、希釈槽における液体試料等の拡散、混合を短時間で
より効率的に行い得る。このような構成により、特に液
体試料として血液試料を取り扱う糖化ヘモグロビン分析
装置の前処理装置等においても効率的な拡散、混合が可
能となるが、この場合には更に血液試料の十分な溶血を
も実現できるという効果がある。なお、シリンジの運動
回数を変更して混合流路を往復させる回数を調整すれ
ば、液体試料の種類に応じた混合度を容易に得ることが
可能である。
By thus reducing the capacity of the diluting tank, the amount of the cleaning solution required for cleaning the diluting tank can be reduced in the present invention. Moreover, in the present invention, by devising the shape of the diluting tank and further equipping the diluting tank with the mixing channel, the liquid sample and the like in the diluting tank can be diffused and mixed efficiently in a short time. With such a configuration, particularly in a pretreatment device of a glycated hemoglobin analyzer that handles a blood sample as a liquid sample, efficient diffusion and mixing are possible, but in this case, sufficient hemolysis of the blood sample is also possible. There is an effect that it can be realized. In addition, it is possible to easily obtain the mixing degree according to the type of the liquid sample by changing the number of times of movement of the syringe and adjusting the number of times of reciprocating the mixing flow path.

【0037】本発明では、図面に例示したように単一の
シリンジと系を切り替える3個のバルブによってニード
ル、希釈槽及び混合流路の洗浄等の前処理を行うことが
可能であり、装置の簡素化、前処理要する時間の短縮化
が可能である。
In the present invention, as shown in the drawing, a single syringe and three valves for switching the system can be used for pretreatment such as washing of the needle, the diluting tank and the mixing flow path. It is possible to simplify and shorten the time required for pretreatment.

【0038】また本発明によれば、希釈槽となる柱状の
孔の洗浄もシリンジからの洗浄溶液の吐出により行うこ
とが可能であり、しかも希釈槽の容量を超えて吐出され
た洗浄溶液は隣接する排液槽にオーバーフローするた
め、希釈槽の上端部の汚染によるコンタミネーションの
軽減に効果的であり、加えて希釈槽洗浄専用の吸引ポン
プ、真空チャンバ及び専用のバルブ等の、従来の装置で
使用されている部品を使用する必要がない。また、洗浄
溶液を希釈槽からオーバーフローさせることにより、希
釈槽の上端部には汚れが付着しないから、この結果、希
釈槽はメンテナンスフリーとすることができる。
Further, according to the present invention, it is possible to clean the columnar hole serving as the diluting tank by discharging the cleaning solution from the syringe, and the cleaning solution discharged in excess of the capacity of the diluting tank is adjacent to the cleaning solution. Since it overflows into the drainage tank, it is effective in reducing contamination due to contamination of the upper end of the dilution tank.In addition, conventional equipment such as a suction pump dedicated to cleaning the dilution tank, a vacuum chamber and a dedicated valve can be used. No need to use used parts. Further, since the cleaning solution overflows from the diluting tank, dirt does not adhere to the upper end portion of the diluting tank, and as a result, the diluting tank can be maintenance-free.

【0039】本発明では、血液等の液体試料の一定量を
採取するためのニードルの洗浄も十分であり、特にニー
ドル洗浄ブロックに取り付けたOリング等のシール部材
がニードルに付着したゴムキャップの摩耗カス等をぬぐ
いつつ、洗浄液をニードルに纏着させてニードルの外周
を洗浄するため、ゴムキャップの摩耗カス等は排液槽に
廃棄され、装置中の配管に流出し、詰まりを発生させる
可能性が小さいという効果もある。
In the present invention, the cleaning of the needle for collecting a fixed amount of a liquid sample such as blood is sufficient, and in particular, the wear of the rubber cap attached to the needle by the sealing member such as the O-ring attached to the needle cleaning block. Since the cleaning liquid is attached to the needle and the outer periphery of the needle is cleaned while wiping off the dust, the abrasion dust of the rubber cap may be discarded in the drainage tank and may flow out to the piping in the device, causing clogging. Also has the effect of being small.

【0040】[0040]

【発明の実施の形態】以下、本発明をグリコヘモグロビ
ン分析装置の前処理装置適用した場合について、実施例
に基づき説明するが、本発明はこれら実施例に限定され
るものではない。
BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the case where the present invention is applied to a pretreatment device for a glycohemoglobin analyzer will be described based on Examples, but the present invention is not limited to these Examples.

【0041】グリコヘモグロビン分析装置への前処理装
置としては、一般に、前処理に要する時間が120秒以
下、前血液試料からの持ち込み(コンタミネーション)
が1%以下、希釈倍率が約250倍、その再現性(C
V)が10%以下であることが要求され、また希釈のみ
ならず、赤血球の溶血をも要求される。
As a pretreatment device for a glycohemoglobin analyzer, generally, the time required for the pretreatment is 120 seconds or less, and it is brought in from a preblood sample (contamination).
Is less than 1%, dilution ratio is about 250 times, its reproducibility (C
V) is required to be 10% or less, and not only dilution but also hemolysis of red blood cells is required.

【0042】使用した前処理装置全体の構成は図2に示
した通りである。希釈・洗浄溶液21としては市販の糖
化ヘモグロビン分析用溶血剤(溶血剤C、東ソー(株)
製)を、血液試料24としては、EDTAを血液凝固阻
害剤として添加した、ゴムキャップ22付き真空採血管
23に採血し、3000rpmで10分の遠沈を行った
後3日を経過し粘性が高くなっているものを用いた。
The structure of the entire pretreatment apparatus used is as shown in FIG. As the diluting / washing solution 21, a commercially available hemolytic agent for glycated hemoglobin analysis (hemolytic agent C, Tosoh Corporation)
As a blood sample 24, blood was collected in a vacuum blood collection tube 23 with a rubber cap 22 and EDTA added as a blood coagulation inhibitor, and after 3 minutes of centrifugation at 3000 rpm for 10 minutes, the viscosity was increased. I used the one that was higher.

【0043】溶液を吸引・吐出するための第一シリンジ
31には容量が2500マイクロlのシリンジを、検体
を吸引・吐出するための第二シリンジ29には容量は2
50マイクロlのシリンジを、第一バルブ34、第二バ
ルブ35、第三バルブ36にはそれぞれ市販の3方電磁
弁(アドバンス(株)製)を、サンプルインジェクタ3
3には市販の6方インジェクションバルブ(レオダイン
(株)製)を用いた。なお、このサンプルインジェクタ
のサンプルループ33aの容量は10マイクロlであ
る。
The first syringe 31 for sucking and discharging the solution has a capacity of 2500 microliters, and the second syringe 29 for sucking and discharging the sample has a capacity of 2 microliters.
A 50 microliter syringe, commercially available 3-way solenoid valves (made by Advance Co., Ltd.) for the first valve 34, the second valve 35, and the third valve 36, respectively, and the sample injector 3
A commercially available 6-way injection valve (manufactured by Rheodyne Co., Ltd.) was used as 3. The capacity of the sample loop 33a of this sample injector is 10 μl.

【0044】ニードル25としては外径が1.25mm
で長さが15.5cm、穴形が0.6mmの開口部がニ
ードル先端から4.2mmの位置に開いているものを用
いた。希釈槽33bに接続される混合流路としては、内
径が2mmで長さが20cmテフロンチューブを材料と
して、乱流が発生するようにその一部を絞って凸凹の断
面積を有するように加工したものを用いた。
The needle 25 has an outer diameter of 1.25 mm.
The length was 15.5 cm and the hole shape was 0.6 mm and the opening was opened 4.2 mm from the tip of the needle. The mixing flow path connected to the diluting tank 33b was made of a Teflon tube having an inner diameter of 2 mm and a length of 20 cm, and was processed so as to have an uneven cross-sectional area by squeezing a part thereof so as to generate turbulent flow. I used one.

【0045】液体試料の希釈のための希釈槽と排液槽が
一体に形成された前処理槽30としては、PMMA(ア
クリル樹脂)製のものを用いた。前処理槽の全体図を図
3aに、希釈槽30bの詳細を図3bに示す。
A PMMA (acrylic resin) tank was used as the pretreatment tank 30 in which a diluting tank for diluting the liquid sample and a drainage tank were integrally formed. A general view of the pretreatment tank is shown in FIG. 3a, and details of the diluting tank 30b are shown in FIG. 3b.

【0046】排液槽30aの開口部の面積は112.2
6mm2であり、希釈槽の孔の軸線と排液槽の孔の軸線
は14mm離間している。希釈槽30bの全長(a)は
47mmで、底面から7mmの地点までは内径が2.5
mmの円柱状、底面7mm〜43mmの地点までは内径
が3mmの円柱状、底面43mm〜47mmの地点まで
は内径が5mmの円柱状と、3段階に断面積が大きくな
る円柱状の孔である。その内容量は367.18マイク
ロlとなるが、ニードルを希釈槽の底面まで下降した状
態での容量は、ニードル分の容積を差し引くと約310
マイクロlとなる。希釈槽周囲の高さ(b)は4.5m
mであるが、排液槽とのしきりは希釈槽上端と同一の高
さで幅(c)1mmとしてあるため、希釈槽からオーバ
ーフローした希釈後試料等は排液槽に流れ込み、前処理
槽から外部に流出しない構造となっている。
The area of the opening of the drainage tank 30a is 112.2.
6 mm 2, and the axis of the hole of the diluting tank and the axis of the hole of the drainage tank are separated by 14 mm. The total length (a) of the diluting tank 30b is 47 mm, and the inner diameter is 2.5 from the bottom to the point 7 mm.
A cylindrical hole having an inner diameter of 3 mm, a bottom surface of 7 mm to 43 mm, and an inner diameter of 3 mm, a bottom surface of 43 mm to 47 mm, and an inner diameter of 5 mm. . The content volume is 376.18 microliters, but the volume with the needle lowered to the bottom of the diluting tank is about 310 when the volume for the needle is subtracted.
It becomes microl. The height (b) around the dilution tank is 4.5 m
However, since the limit to the drainage tank is the same height as the upper end of the diluting tank and the width (c) is 1 mm, the diluted sample etc. overflowing from the diluting tank flows into the draining tank and is discharged from the pretreatment tank. It has a structure that does not leak to the outside.

【0047】ニードル洗浄ブロック28は、全長40m
m、幅20mm、奥行き40mmのPMMA(アクリル
樹脂)製のブロックに、ニードル洗浄路として内径が
1.8mmで全長が40mmの円柱形の孔を形成したも
のを用いた。ニードルの洗浄路の上端から5mmの位置
にニードル洗浄路に直角に接続するする内径0.8mm
の洗浄液導入路を形成し、かつ、ニードル洗浄路上端の
開口にはシール材として内径が1.2mmのOリングを
固着し、更に下端には内径が1.8mm、長さ5mmの
中空部を有するの円柱形のノズルを固着し、洗浄液が排
液槽30aに廃棄され易いようにした。
The needle washing block 28 has a total length of 40 m.
A block made of PMMA (acrylic resin) having a size of m, a width of 20 mm, and a depth of 40 mm was used as a needle washing passage having a cylindrical hole having an inner diameter of 1.8 mm and a total length of 40 mm. An inner diameter of 0.8 mm that connects to the needle washing path at a position 5 mm from the upper end of the needle washing path at a right angle.
Of the washing liquid introduction path, and an O-ring having an inner diameter of 1.2 mm is fixed as a sealing material at the opening at the upper end of the needle washing path, and a hollow portion having an inner diameter of 1.8 mm and a length of 5 mm is further provided at the lower end. The columnar nozzle is fixed so that the cleaning liquid can be easily discarded in the drainage tank 30a.

【0048】前記混合流路32以外の配管は、内径0.
8mmのテフロン管を使用した。
The pipes other than the mixing channel 32 have an inner diameter of 0.
An 8 mm Teflon tube was used.

【0049】血液試料のニードルによる採取量を3マイ
クロlとし、希釈槽に吐出する洗浄・希釈溶液は600
マイクロlとし、吐出速度は131マイクロl/秒とし
た。希釈槽の容量は310マイクロlであり、290マ
イクロlが排液槽30aにオーバーフローすることにな
る。ニードルの洗浄は、ニードルを3回上下往復動させ
つつ900マイクロlの希釈・洗浄液を用いて行い、希
釈槽と混合流路の洗浄はこれら部分の合計容量が36
7.18マイクロlであるのに対して、1342マイク
ロlの希釈・洗浄溶液を吐出して行った。
The amount of the blood sample collected by the needle was set to 3 μl, and the washing / diluting solution discharged to the diluting tank was 600
The discharge rate was 131 μl / sec. The capacity of the diluting tank is 310 μl, and 290 μl overflows into the drainage tank 30a. The needle is washed with 900 μl of diluting / washing liquid while reciprocating the needle three times up and down, and the diluting tank and the mixing channel are washed with a total volume of 36 parts.
While the amount was 7.18 μl, 1342 μl of the diluted / washing solution was discharged.

【0050】希釈後試料を混合流路で混合する操作は、
第一シリンジを往復動させることにより希釈後試料を当
該流路を3往復動させて行った。前処理した血液試料を
サンプルインジェクタによって陽イオン交換樹脂を充填
したカラムに供した後、余剰となった希釈後試料をニー
ドルから排液槽に吐出し、更に300マイクロlの希釈
・洗浄溶液を吐出してサンプリング系の配管内及びニー
ドルを洗浄した。
The operation of mixing the diluted sample in the mixing channel is as follows.
The sample was diluted by reciprocating the first syringe, and the sample was reciprocated three times in the flow path. After the pretreated blood sample is applied to the column filled with cation exchange resin by the sample injector, the excess diluted sample is discharged from the needle into the drainage tank, and further 300 μl of diluted / washed solution is discharged. Then, the piping of the sampling system and the needle were washed.

【0051】以上の操作に要した時間は約110秒であ
った。また、本発明の前処理装置による前処理操作、特
に混合操作は十分であり、その結果、血球の溶血も十分
であったため、分析結果は良好であった。また、この前
処理操作を実施した後、糖化ヘモグロビン成分を含まな
い液体試料を用いて同様の前処理操作を行った結果、前
回の血液試料の残存(コンタミネーション)によると思
われるクロマトグラムピークはほとんど認められなかっ
た。更に、得られた血球の絶対量を示すクロマトグラム
の面積は、手動による250倍の前処理(希釈)を行っ
た場合とほぼ同等であった。
The time required for the above operation was about 110 seconds. Further, the pretreatment operation by the pretreatment apparatus of the present invention, especially the mixing operation was sufficient, and as a result, the hemolysis of blood cells was also sufficient, so the analysis result was good. After performing this pretreatment operation, a similar pretreatment operation was performed using a liquid sample that did not contain glycated hemoglobin components.As a result, the chromatogram peak that was probably due to the remaining blood sample (contamination) was It was hardly recognized. Further, the area of the obtained chromatogram showing the absolute amount of blood cells was almost the same as that in the case where the manual pretreatment (dilution) of 250 times was performed.

【0052】同一の血液試料を用いて前処理(希釈)の
再現性を観察したところ、10回の前処理操作における
再現性はcv=1.26%であった。
When the reproducibility of the pretreatment (dilution) was observed using the same blood sample, the reproducibility after 10 pretreatment operations was cv = 1.26%.

【0053】以上に説明した、本発明の前処理装置を適
用したグリコヘモグロビン分析装置を用いて真空採血管
に採取されたヒト血液8000検体の分析を実施した結
果、排液槽にニードルに付着したゴムキャップのカスが
廃棄され、希釈槽については汚染(汚れ)は確認され
ず、また詰まりなどの不具合も生じることはなかった。
Using the glycohemoglobin analyzer to which the pretreatment device of the present invention described above was applied, 8000 samples of human blood collected in a vacuum blood collection tube were analyzed, and as a result, adhered to the needle in the drainage tank. The scraps of the rubber cap were discarded, no contamination (dirt) was confirmed in the diluting tank, and no trouble such as clogging occurred.

【図面の簡単な説明】[Brief description of drawings]

【図1】図1は、糖化ヘモグロビン分析装置に適用され
た、従来の前処理装置を示す図である。
FIG. 1 is a diagram showing a conventional pretreatment device applied to a glycated hemoglobin analyzer.

【図2】図2は、糖化ヘモグロビン分析装置に適用し
た、本発明の分析装置を示す図である。
FIG. 2 is a diagram showing an analyzer of the present invention applied to a glycated hemoglobin analyzer.

【図3】図3は、実施例で使用した液体試料の希釈のた
めの希釈槽と排液槽が一体に形成された前処理槽の詳細
を示した図である。図中、図3aは前処理槽の全体を示
し、図3bは希釈槽のみを示す。
FIG. 3 is a diagram showing details of a pretreatment tank in which a diluting tank for diluting a liquid sample used in an example and a drainage tank are integrally formed. In the figure, FIG. 3a shows the whole pretreatment tank, and FIG. 3b shows only the diluting tank.

【符号の説明】[Explanation of symbols]

1 ニードル 2 サンプリング位置 3 ゴムキャップ付真空採血管 4 第一シリンジ 5 第一バルブ 6 希釈槽 7 第二シリンジ 8 希釈ノズル 9 第二バルブ 10 サンプルインジェクタ 11 ニードル洗浄ブロック 12 洗浄ポンプ 13 ニードル洗浄槽 14 第三バルブ 15 吸引ポンプ 16 真空チャンバ 17 第四バルブ 18 排出部 19 第五バルブ 21 希釈・洗浄溶液 22 ゴムキャップ 23 真空採血管 24 血液試料 25 ニードル 26 ニードル保持機構 28 ニードル洗浄ブロック 29 第二シリンジ 30 希釈槽と排液槽が一体に形成された前処理槽 30a 排液槽 30b 希釈槽 30c 排液槽と希釈槽間のしきり 31 第一シリンジ 32 混合流路 33 サンプルインジェクタ 33a サンプルループ 34 第一バルブ 35 第二バルブ 36 第三バルブ 1 Needle 2 Sampling Position 3 Vacuum Blood Collection Tube with Rubber Cap 4 First Syringe 5 First Valve 6 Diluting Tank 7 Second Syringe 8 Diluting Nozzle 9 Second Valve 10 Sample Injector 11 Needle Washing Block 12 Washing Pump 13 Needle Washing Tank 14th Three valves 15 Suction pump 16 Vacuum chamber 17 Fourth valve 18 Discharge part 19 Fifth valve 21 Dilution / washing solution 22 Rubber cap 23 Vacuum blood collection tube 24 Blood sample 25 Needle 26 Needle holding mechanism 28 Needle washing block 29 Second syringe 30 Dilution Pretreatment tank in which a tank and a drainage tank are integrally formed 30a Drainage tank 30b Dilution tank 30c Threshold between drainage tank and dilution tank 31 First syringe 32 Mixing channel 33 Sample injector 33a Sample loop 34 First valve 35 Second valve 36 Third valve

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】少なくとも、前処理されるべき液体試料の
一定量を採取するためのニードルと、当該ニードルを上
下動可能に保持するニードル保持機構と、ニードル保持
機構を水平方向に移動可能に保持する基台と、ニードル
保持機構に設置されニードルと共に水平方向に移動可能
であるが上下動しないニードル洗浄ブロックと、液体試
料の希釈のための希釈槽と排液を廃棄するための排液槽
が一体に形成された前処理槽と、希釈された液体試料を
混合するための混合流路と、これら各部品を連結する配
管及び少なくとも二つのシリンジとから構成される、前
処理装置。
1. A needle for collecting at least a fixed amount of a liquid sample to be pretreated, a needle holding mechanism for holding the needle so as to be vertically movable, and a needle holding mechanism for holding the needle so as to be movable in a horizontal direction. The base, the needle wash block installed in the needle holding mechanism that can move horizontally with the needle but does not move up and down, the dilution tank for diluting the liquid sample, and the drain tank for discarding the drainage liquid. A pretreatment device comprising a pretreatment tank integrally formed, a mixing flow path for mixing a diluted liquid sample, a pipe connecting these components, and at least two syringes.
【請求項2】液体試料が血液試料であることを特徴とす
る請求項1の前処理装置。
2. The pretreatment apparatus according to claim 1, wherein the liquid sample is a blood sample.
【請求項3】糖化ヘモグロビン分析装置の前処理部とし
て適用されたことを特徴とする請求項1の前処理装置。
3. The pretreatment device according to claim 1, which is applied as a pretreatment part of a glycated hemoglobin analyzer.
JP08254196A 1996-04-04 1996-04-04 Pretreatment device Expired - Fee Related JP3572792B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP08254196A JP3572792B2 (en) 1996-04-04 1996-04-04 Pretreatment device
EP97302315A EP0800073B1 (en) 1996-04-04 1997-04-04 Pretreatment apparatus
US08/832,670 US6066298A (en) 1996-04-04 1997-04-04 Pretreatment apparatus
DE69730893T DE69730893T2 (en) 1996-04-04 1997-04-04 pretreatment device
US09/432,776 US6190614B1 (en) 1996-04-04 1999-11-03 Pretreatment apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP08254196A JP3572792B2 (en) 1996-04-04 1996-04-04 Pretreatment device

Publications (2)

Publication Number Publication Date
JPH09274048A true JPH09274048A (en) 1997-10-21
JP3572792B2 JP3572792B2 (en) 2004-10-06

Family

ID=13777374

Family Applications (1)

Application Number Title Priority Date Filing Date
JP08254196A Expired - Fee Related JP3572792B2 (en) 1996-04-04 1996-04-04 Pretreatment device

Country Status (4)

Country Link
US (2) US6066298A (en)
EP (1) EP0800073B1 (en)
JP (1) JP3572792B2 (en)
DE (1) DE69730893T2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002031626A (en) * 2000-05-09 2002-01-31 Tosoh Corp Saccharified hemoglobin analyzer
JP2004144633A (en) * 2002-10-25 2004-05-20 Sysmex Corp Sample analysis apparatus and pipette cleaning dilution liquid used for the same
JP2004317420A (en) * 2003-04-18 2004-11-11 Hitachi Software Eng Co Ltd Measuring instrument using capillary
JP2007101311A (en) * 2005-10-03 2007-04-19 Sysmex Corp Specimen analyzer
JP2012047749A (en) * 1998-10-15 2012-03-08 Particle Sizing Systems Inc Automatic dilution system for high-resolution particle size analysis
JP2012068233A (en) * 2010-08-25 2012-04-05 Arkray Inc Analysis device and analysis method
JP2012247224A (en) * 2011-05-25 2012-12-13 Tosoh Corp Specimen dilution apparatus
JP2012251805A (en) * 2011-05-31 2012-12-20 Toshiba Corp Automatic analyzer
JP2013040879A (en) * 2011-08-18 2013-02-28 Tosoh Corp Analyzer with analyte diluting device
JP2019158451A (en) * 2018-03-09 2019-09-19 東洋紡株式会社 Dilution-dispensation nozzle cleaning container, dispensation-dilution system, and automatic analyzer
JP2020160000A (en) * 2019-03-28 2020-10-01 シスメックス株式会社 Method for cleaning aspiration tube and specimen measuring apparatus

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6315952B1 (en) * 1998-10-05 2001-11-13 The University Of New Mexico Plug flow cytometry for high throughput screening and drug discovery
ATE246144T1 (en) * 1999-12-01 2003-08-15 Procter & Gamble PRODUCT DELIVERY DEVICE
DE10001895A1 (en) * 2000-01-19 2001-07-26 Mettler Toledo Gmbh Analysis device and drive device therefor
EP1154270B1 (en) * 2000-05-09 2015-01-21 Tosoh Corporation Glycated hemoglobin analyzer
JP2002001092A (en) * 2000-06-22 2002-01-08 Shimadzu Corp Apparatus for discharging liquid
US7439076B1 (en) * 2000-06-30 2008-10-21 Hitachi, Ltd. Liquid dispensing method and device
JP3665257B2 (en) * 2000-07-11 2005-06-29 株式会社日立製作所 Dispensing device
US6852291B1 (en) * 2000-10-11 2005-02-08 Innovadyne Technologies, Inc. Hybrid valve apparatus and method for fluid handling
US7135146B2 (en) * 2000-10-11 2006-11-14 Innovadyne Technologies, Inc. Universal non-contact dispense peripheral apparatus and method for a primary liquid handling device
US6887429B1 (en) * 2001-01-26 2005-05-03 Global Fia Apparatus and method for automated medical diagnostic tests
FI20010190A (en) 2001-02-01 2002-08-02 Niilo Kaartinen Method used to test the fluid samples, test unit applying the method and system containing test units
US7198956B2 (en) * 2001-06-13 2007-04-03 Uffenheimer Kenneth F Automated fluid handling system and method
US6526812B2 (en) 2001-07-14 2003-03-04 Leap Technologies, Inc. Self-washing injection apparatus
US6983636B2 (en) 2002-01-25 2006-01-10 Innovadyne Technologies, Inc. Apparatus and method for assessing the liquid flow performances through a small dispensing orifice
US7288228B2 (en) * 2002-02-12 2007-10-30 Gilson, Inc. Sample injection system
GB0218949D0 (en) * 2002-08-14 2002-09-25 Thermo Electron Corp Pumping and diluting a sample for analysis
GB0218946D0 (en) 2002-08-14 2002-09-25 Thermo Electron Corp Diluting a sample
WO2004063754A1 (en) * 2003-01-13 2004-07-29 Pfizer Products Inc. System for rinsing a sample probe comprising a probe guide support
JP3826891B2 (en) * 2003-03-05 2006-09-27 株式会社島津製作所 Autosampler
EP2413136B1 (en) 2003-07-18 2013-07-03 Bio-Rad Laboratories, Inc. System and method for multi-analyte detection
US8012768B2 (en) 2003-07-18 2011-09-06 Bio-Rad Laboratories, Inc. System and method for multi-analyte detection
US7422905B2 (en) * 2004-02-27 2008-09-09 Medtronic, Inc. Blood coagulation test cartridge, system, and method
US7439069B2 (en) * 2004-02-27 2008-10-21 Nippoldt Douglas D Blood coagulation test cartridge, system, and method
US7399637B2 (en) * 2004-04-19 2008-07-15 Medtronic, Inc. Blood coagulation test cartridge, system, and method
US7621282B2 (en) * 2004-06-17 2009-11-24 Abbott Laboratories, Inc. Probe washing cups and methods
US7628954B2 (en) * 2005-05-04 2009-12-08 Abbott Laboratories, Inc. Reagent and sample handling device for automatic testing system
US20080034900A1 (en) * 2006-08-09 2008-02-14 Bollinger David S Apparatus and method to sample a material for later analysis
WO2008140707A1 (en) * 2007-05-11 2008-11-20 Bio-Rad Laboratories, Inc. Wash ring assembly and method of use
JP5162177B2 (en) * 2007-07-31 2013-03-13 シスメックス株式会社 Particle analyzer and particle analysis method
CN101799400B (en) * 2009-02-05 2011-09-28 浙江雷畴科技有限公司 Online optical liquid detection analysis device
JP5111476B2 (en) * 2009-10-26 2013-01-09 株式会社日立ハイテクノロジーズ Liquid sample analyzer and liquid sample introduction device
US8733152B2 (en) * 2010-01-19 2014-05-27 Bio-Rad Laboratories, Inc. Automated analyzer with low-pressure in-line filtration
JP2012117945A (en) * 2010-12-02 2012-06-21 Hitachi High-Technologies Corp Liquid chromatograph, sample introduction device for liquid chromatograph, and cleaning method of sample introduction device for liquid chromatograph
JP6181039B2 (en) * 2012-02-22 2017-08-16 株式会社日立ハイテクノロジーズ Automatic analyzer
JP5799889B2 (en) * 2012-05-15 2015-10-28 株式会社島津製作所 Preparative purification equipment
CN103447268A (en) * 2012-06-05 2013-12-18 北京普源精电科技有限公司 Automatic sample feeder and needle bath thereof
KR101478458B1 (en) * 2013-08-29 2014-12-31 김보곤 Blood viscosity measurement apparatus for washing blood
CA2967893C (en) * 2014-12-10 2022-09-27 Wallac Oy A dispenser device and a method for rinsing the dispenser device
CN105842366B (en) * 2015-01-15 2018-01-23 株式会社岛津制作所 Sample injection device
CN105457951A (en) * 2015-12-30 2016-04-06 聚光科技(杭州)股份有限公司 Cleaning device and method
WO2017141626A1 (en) * 2016-02-19 2017-08-24 株式会社日立ハイテクノロジーズ Automated analysis device
EP3460467A4 (en) * 2016-05-20 2020-04-15 Shimadzu Corporation Preprocessing device and analysis system provided with preprocessing device
WO2019231918A1 (en) * 2018-05-29 2019-12-05 Waters Technologies Corporation Online sample manager
CN114200070A (en) * 2021-12-14 2022-03-18 嘉兴市唯真生物科技有限公司 Liquid chromatography device

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5033876B1 (en) * 1970-12-29 1975-11-04
JPS5139382B2 (en) * 1972-02-17 1976-10-27
JPS5523417A (en) * 1978-07-25 1980-02-19 Seishin Seiyaku Kk Automatic sample supply unit
JPS60263850A (en) * 1984-06-12 1985-12-27 Toshiba Corp Analyzing device
JPS6182275U (en) * 1984-11-02 1986-05-31
JPS61169736A (en) * 1985-01-17 1986-07-31 デイド・ケミストリー・システムズ・インコーポレイテッド Liquid pipet device and pipet method
JPS61234336A (en) * 1985-04-11 1986-10-18 Aloka Co Ltd Liquid distribution
JPS6325559A (en) * 1986-06-23 1988-02-03 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー Liquid distributor
US4730631A (en) * 1985-07-22 1988-03-15 Sequoia-Turner Corporation Probe wash station
JPS63139256A (en) * 1986-11-14 1988-06-11 ソシエテ アベイクス Washer of needle for extracting liquid sample
JPH0197857A (en) * 1987-07-14 1989-04-17 Kyoto Daiichi Kagaku:Kk Automatic measuring method of glycosylated hemoglobin and sample introducing valve
US4989623A (en) * 1989-12-01 1991-02-05 Akzo N.V. Apparatus and method for cleaning reagent delivery probes
JPH0361572U (en) * 1989-10-20 1991-06-17
JPH04105066A (en) * 1990-08-24 1992-04-07 Olympus Optical Co Ltd Probe washing vessel
JPH0631148A (en) * 1992-07-15 1994-02-08 Nikkiso Co Ltd Device and method for diluting reagent
JPH06222065A (en) * 1992-12-17 1994-08-12 Smithkline Beckman Corp Device and method for cleaning fluid probe
JPH06294802A (en) * 1993-04-12 1994-10-21 Olympus Optical Co Ltd Automatic analyzer
JPH0798320A (en) * 1993-09-29 1995-04-11 Shimadzu Corp Biochemical automatic analyzer
JPH0798306A (en) * 1993-09-29 1995-04-11 Sekisui Chem Co Ltd Measuring method for stable saccharified hemoglobin
JPH07113779A (en) * 1993-10-19 1995-05-02 Olympus Optical Co Ltd Analyzer
JPH07229905A (en) * 1993-12-20 1995-08-29 Toa Medical Electronics Co Ltd Apparatus for cleaning pipette
JPH08178824A (en) * 1994-12-21 1996-07-12 Toa Medical Electronics Co Ltd Particle measuring apparatus
JPH09171024A (en) * 1995-12-19 1997-06-30 Toa Medical Electronics Co Ltd Sample stirrer
JPH09274029A (en) * 1996-04-04 1997-10-21 Tosoh Corp Saccharized hemoglobin analyzer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3192968A (en) * 1962-07-02 1965-07-06 Warner Lambert Pharmaceutical Apparatus for performing analytical procedures
JPS5782769A (en) * 1980-11-10 1982-05-24 Hitachi Ltd Automatic analyzing device
JPS5848836A (en) * 1981-09-18 1983-03-22 Toa Medical Electronics Co Ltd Optical type automatic analyzing and measuring device
US4946651A (en) * 1985-11-15 1990-08-07 Smithkline Diagnostics, Inc. Sample holder for a body fluid analyzer
US4948563A (en) * 1987-05-08 1990-08-14 Abbott Laboratories Waste container insert for washing automated immunoassay apparatus probe
DE3885021T2 (en) * 1987-07-14 1994-05-19 Kyoto Daiichi Kagaku Kyoto Kk Automatic measurement method for glycohemoglobin.
FR2629207B1 (en) * 1988-07-07 1991-05-31 Melet Francois AUTOMATIC HEMATOLOGICAL ANALYZER WITH SIMPLIFIED SAMPLING AND DISPENSING DEVICE
US5132233A (en) * 1989-03-13 1992-07-21 Beckman Instruments, Inc. Sample injection cell
US5558838A (en) * 1993-09-29 1996-09-24 Becton Dickinson And Company Sample preparation apparatus
US5730938A (en) * 1995-08-09 1998-03-24 Bio-Chem Laboratory Systems, Inc. Chemistry analyzer

Patent Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5033876B1 (en) * 1970-12-29 1975-11-04
JPS5139382B2 (en) * 1972-02-17 1976-10-27
JPS5523417A (en) * 1978-07-25 1980-02-19 Seishin Seiyaku Kk Automatic sample supply unit
JPS60263850A (en) * 1984-06-12 1985-12-27 Toshiba Corp Analyzing device
JPS6182275U (en) * 1984-11-02 1986-05-31
JPS61169736A (en) * 1985-01-17 1986-07-31 デイド・ケミストリー・システムズ・インコーポレイテッド Liquid pipet device and pipet method
JPS61234336A (en) * 1985-04-11 1986-10-18 Aloka Co Ltd Liquid distribution
US4730631A (en) * 1985-07-22 1988-03-15 Sequoia-Turner Corporation Probe wash station
JPS6325559A (en) * 1986-06-23 1988-02-03 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー Liquid distributor
JPS63139256A (en) * 1986-11-14 1988-06-11 ソシエテ アベイクス Washer of needle for extracting liquid sample
JPH0197857A (en) * 1987-07-14 1989-04-17 Kyoto Daiichi Kagaku:Kk Automatic measuring method of glycosylated hemoglobin and sample introducing valve
JPH0361572U (en) * 1989-10-20 1991-06-17
US4989623A (en) * 1989-12-01 1991-02-05 Akzo N.V. Apparatus and method for cleaning reagent delivery probes
JPH04105066A (en) * 1990-08-24 1992-04-07 Olympus Optical Co Ltd Probe washing vessel
JPH0631148A (en) * 1992-07-15 1994-02-08 Nikkiso Co Ltd Device and method for diluting reagent
JPH06222065A (en) * 1992-12-17 1994-08-12 Smithkline Beckman Corp Device and method for cleaning fluid probe
JPH06294802A (en) * 1993-04-12 1994-10-21 Olympus Optical Co Ltd Automatic analyzer
JPH0798320A (en) * 1993-09-29 1995-04-11 Shimadzu Corp Biochemical automatic analyzer
JPH0798306A (en) * 1993-09-29 1995-04-11 Sekisui Chem Co Ltd Measuring method for stable saccharified hemoglobin
JPH07113779A (en) * 1993-10-19 1995-05-02 Olympus Optical Co Ltd Analyzer
JPH07229905A (en) * 1993-12-20 1995-08-29 Toa Medical Electronics Co Ltd Apparatus for cleaning pipette
JPH08178824A (en) * 1994-12-21 1996-07-12 Toa Medical Electronics Co Ltd Particle measuring apparatus
JPH09171024A (en) * 1995-12-19 1997-06-30 Toa Medical Electronics Co Ltd Sample stirrer
JPH09274029A (en) * 1996-04-04 1997-10-21 Tosoh Corp Saccharized hemoglobin analyzer

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012047749A (en) * 1998-10-15 2012-03-08 Particle Sizing Systems Inc Automatic dilution system for high-resolution particle size analysis
JP2002031626A (en) * 2000-05-09 2002-01-31 Tosoh Corp Saccharified hemoglobin analyzer
JP2004144633A (en) * 2002-10-25 2004-05-20 Sysmex Corp Sample analysis apparatus and pipette cleaning dilution liquid used for the same
JP2004317420A (en) * 2003-04-18 2004-11-11 Hitachi Software Eng Co Ltd Measuring instrument using capillary
JP2007101311A (en) * 2005-10-03 2007-04-19 Sysmex Corp Specimen analyzer
JP2012068233A (en) * 2010-08-25 2012-04-05 Arkray Inc Analysis device and analysis method
JP2012247224A (en) * 2011-05-25 2012-12-13 Tosoh Corp Specimen dilution apparatus
JP2012251805A (en) * 2011-05-31 2012-12-20 Toshiba Corp Automatic analyzer
JP2013040879A (en) * 2011-08-18 2013-02-28 Tosoh Corp Analyzer with analyte diluting device
JP2019158451A (en) * 2018-03-09 2019-09-19 東洋紡株式会社 Dilution-dispensation nozzle cleaning container, dispensation-dilution system, and automatic analyzer
JP2020160000A (en) * 2019-03-28 2020-10-01 シスメックス株式会社 Method for cleaning aspiration tube and specimen measuring apparatus
US11666920B2 (en) 2019-03-28 2023-06-06 Sysmex Corporation Method of cleaning aspiration tube and specimen measuring apparatus

Also Published As

Publication number Publication date
EP0800073A2 (en) 1997-10-08
DE69730893D1 (en) 2004-11-04
EP0800073A3 (en) 1998-04-22
US6190614B1 (en) 2001-02-20
US6066298A (en) 2000-05-23
JP3572792B2 (en) 2004-10-06
DE69730893T2 (en) 2005-02-03
EP0800073B1 (en) 2004-09-29

Similar Documents

Publication Publication Date Title
JP3572792B2 (en) Pretreatment device
US8171946B2 (en) Probe washing cups and methods
WO2011027410A1 (en) Automatic sampler
US5512248A (en) Twin-probe blood sample diluting device
JP5341083B2 (en) Fluid Sample Preparation and Fraction Dispensing Equipment, Dispensing System Containing This Equipment, and Related Methods
EP0571611B1 (en) Probe wash for liquid analysis apparatus
US4799393A (en) Combined closed and open tube sampling apparatus and method
JPH07229905A (en) Apparatus for cleaning pipette
JPH09318522A (en) Particle detector and partcle analyzer
JP5878138B2 (en) Sample analyzer
JP2002040035A (en) Biochemical automatic analyzer
JPH076997B2 (en) Sampling device and method
JPH04105065A (en) Cup washing device
JPH02223860A (en) Sampling tube washing device
WO2013069769A1 (en) Sample injection device for biochemical analysis, flow-type biochemical analysis device, and measurement method for hemoglobin component
JP2828711B2 (en) Method and apparatus for supplying sample liquid
JPH0242362A (en) Cleaning device for automatic analyzing device
JP4347084B2 (en) SUMIYA ANALYSIS DEVICE AND SUMIYA ANALYSIS METHOD
JP5310861B2 (en) Autosampler
CN219130198U (en) Liquid device for removing outer wall of sampling needle of glycosylated hemoglobin instrument
JPH07103984A (en) Automatic chemical analyser
JPH01233342A (en) Method and apparatus for multipointed sampling of reagent solution
JPS63246676A (en) Sample introducing apparatus
JPH08313426A (en) Analyser
JPS58108459A (en) Device for collection of blood

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040608

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040621

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20070709

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080709

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090709

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100709

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110709

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110709

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120709

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120709

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130709

Year of fee payment: 9

LAPS Cancellation because of no payment of annual fees